EUVIMEDEUVIMED entdecken
Crossref

Analysis of cost-effectiveness of chemotherapeutic agents and new therapies for the management of unresectable and metastatic melanoma

Clément Charpentier, Valéry-Pierre Riche, Jean-Michel Nguyen, Romain Guile, Émilie Varey, Clémentine Fronteau, Laurent Flet, Patrick Thomare, Alexandra Poinas, Amir Khammari, Brigitte Dreno

European Journal of Dermatology · 2023

DOI: 10.1684/ejd.2023.4448 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Dermatology, 2023. Verfasst von Clément Charpentier und 10 weiteren Autor:innen. Beteiligte Einrichtung: Oncodermatology department, Nantes University Hospital, Nantes, France, Nantes Université, Univ Angers, INSERM, Immunology and New Concepts in Immuno…. Hauptthemen laut MEDLINE: Melanoma, Neoplasms, Second Primary. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaNeoplasms, Second PrimaryMaleHumansFemaleCost-Benefit AnalysisRetrospective StudiesCost-Effectiveness AnalysisDacarbazine

Stichwörter der Autor:innen

cost-effectivenessimmunotherapiesmelanomapublic healthtargeted therapies

Substanzen

Dacarbazine

Autor:innen und Institutionen

  • Oncodermatology department, Nantes University Hospital, Nantes, France, Nantes Université, Univ Angers, INSERM, Immunology and New Concepts in Immunotherapy, INCIT, UMR 1302, Nantes, France.
  • Head of clinical research and Innovation, Nantes university Hospital, Nantes, France.
  • SEME, Saint-Jacques Hospital,CRCINA, Nantes University, Nantes, France.
  • IT department, Nantes University Hospital, Nantes, France.
  • Pharmacy department, Nantes University Hospital, Nantes, France.
  • Clinical Investigation Center, Nantes University Hospital, CIC1413, Nantes, France.

Zitieren

APA

Charpentier, C., Riche, V. P., Nguyen, J. M., Guile, R., Varey, É., Fronteau, C., Flet, L., Thomare, P., Poinas, A., Khammari, A., & Dreno, B. (2023). Analysis of cost-effectiveness of chemotherapeutic agents and new therapies for the management of unresectable and metastatic melanoma. European Journal of Dermatology. https://doi.org/10.1684/ejd.2023.4448

Vancouver

Charpentier C, Riche VP, Nguyen JM, Guile R, Varey É, Fronteau C, et al. Analysis of cost-effectiveness of chemotherapeutic agents and new therapies for the management of unresectable and metastatic melanoma. European Journal of Dermatology. 2023. doi:10.1684/ejd.2023.4448

BibTeX
@article{Charpentier2023,
  author = {Charpentier, Clément and Riche, Valéry-Pierre and Nguyen, Jean-Michel and Guile, Romain and Varey, Émilie and Fronteau, Clémentine and Flet, Laurent and Thomare, Patrick and Poinas, Alexandra and Khammari, Amir and Dreno, Brigitte},
  title = {Analysis of cost-effectiveness of chemotherapeutic agents and new therapies for the management of unresectable and metastatic melanoma},
  journal = {European Journal of Dermatology},
  year = {2023},
  doi = {10.1684/ejd.2023.4448}
}
Kostenlos starten →